zelvartancombo 160 mg/25 mg filmsko obložene tablete
galex d.d. - hidroklorotiazid; valsartan - filmsko obložena tableta - hidroklorotiazid 25 mg / 1 tableta valsartan160 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in diuretiki
valsaden 160 mg/12,5 mg filmsko obložene tablete
krka, d.d., novo mesto - hidroklorotiazid, valsartan - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in diuretiki
valsaden 160 mg/25 mg filmsko obložene tablete
krka, d.d., novo mesto - hidroklorotiazid, valsartan - filmsko obložena tableta - hidroklorotiazid 25 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in diuretiki
zelvartancombo 160 mg/12,5 mg filmsko obložene tablete
galex d.d. - hidroklorotiazid; valsartan - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta valsartan160 mg / 1 tableta; valsartan 160 mg / 1 tableta - valsartan in diuretiki
zelvartancombo 80 mg/12,5 mg filmsko obložene tablete
galex d.d. - hidroklorotiazid; valsartan - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta valsartan80 mg / 1 tableta; valsartan 80 mg / 1 tableta - valsartan in diuretiki
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
lumigan
abbvie deutschland gmbh & co. kg - bimatoprost - glaucoma, open-angle; ocular hypertension - prostaglandin analogues, ophthalmologicals - zmanjšanje zvišanega očesnega tlaka pri kroničnem glavkomu odprtega zakotja in očesni hipertenziji (kot monoterapija ali kot dodatno zdravljenje zaviralcev beta).
lysvulpen
bioveta -
roclanda
santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - oftalmologi - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.
azarga
novartis europharm limited - brinzolamide, timolol maleate - glaucoma, open-angle; ocular hypertension - oftalmologi - zmanjšanje intraokularnega tlaka (iop) pri odraslih bolnikih z glavkomom odprtega zakotja ali očesno hipertenzijo, pri kateri monoterapija ne zagotavlja zadostnega znižanja iop.